Krystal Biotech Inc
(KRYS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 153,431 | 74,067 | 35,733 | 89,159 | 43,680 |
| Depreciation Amortization | 4,789 | 3,177 | 1,634 | 6,714 | 5,159 |
| Income taxes - deferred | -24,680 | N/A | N/A | N/A | N/A |
| Accounts receivable | -24,616 | -6,693 | 1,486 | -62,706 | -55,257 |
| Accounts payable and accrued liabilities | 1,009 | 5,029 | 906 | 1,011 | 1,602 |
| Other Working Capital | -45,918 | -18,041 | -18,535 | -14,457 | -8,796 |
| Other Operating Activity | 59,342 | 26,159 | 9,745 | 103,699 | 84,189 |
| Operating Cash Flow | $123,357 | $83,698 | $30,969 | $123,420 | $70,577 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -60,203 | -57,621 | -49,000 | -159,201 | -76,224 |
| PPE Investments | -9,377 | -7,673 | -5,769 | -4,238 | -3,437 |
| Investing Cash Flow | $-69,580 | $-65,294 | $-54,769 | $-163,439 | $-79,661 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,972 | 3,258 | 1,462 | 32,400 | 29,972 |
| Other Financing Activity | -13,933 | -13,928 | -13,928 | -5,386 | -5,386 |
| Financing Cash Flow | $-6,961 | $-10,670 | $-12,466 | $27,014 | $24,586 |
| Exchange Rate Effect | 923 | 1,230 | 171 | -458 | 136 |
| Beginning Cash Position | 344,865 | 344,865 | 344,865 | 358,328 | 358,328 |
| End Cash Position | 392,604 | 353,829 | 308,770 | 344,865 | 373,966 |
| Net Cash Flow | $47,739 | $8,964 | $-36,095 | $-13,463 | $15,638 |
| Free Cash Flow | |||||
| Operating Cash Flow | 123,357 | 83,698 | 30,969 | 123,420 | 70,577 |
| Capital Expenditure | -9,812 | -8,108 | -6,204 | -4,238 | -3,437 |
| Free Cash Flow | 113,545 | 75,590 | 24,765 | 119,182 | 67,140 |